ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area

- Lucile Packard Children’s Hospital Stanford is ready to accept patients for ZEVASKYN treatment -

- Abeona Therapeutics^® and Stanford Medicine conducted research collaboration for more than a decade, culminating in U.S. Food and Drug Administration (FDA) approval of ZEVASKYN in April 2025 -

Read more at globenewswire.com